		December 28, 2024			December 30, 2023			December 31, 2022
Numerator
Earnings (loss) from continuing operations	$	(11,474	)	$	(25,181	)	$	2,289
Less: dividends and accretion on preferred stock		(539	)		(1,981	)		(3,109	)
Loss from continuing operations attributable to common shareholders		(12,013	)		(27,162	)		(820	)
Net loss from discontinued operations		(5,919	)		(153,608	)		(8,722	)
Loss attributable to common shareholders	$	(17,932	)	$	(180,770	)	$	(9,542	)

Denominator
Basic weighted-average number of shares outstanding		116,617			114,226			107,659
Dilutive effect of the following:
Stock options and restricted stock units⁽¹⁾		-			-			-
Series B-1 Preferred Stock⁽²⁾		-			-			-
Diluted weighted-average number of shares outstanding		116,617			114,226			107,659

Basic and Diluted Loss Per Share
Loss from continuing operations attributable to common shareholders	$	(0.10	)	$	(0.24	)	$	(0.01	)
Net loss from discontinued operations		(0.05	)		(1.34	)		(0.08	)
Loss attributable to common shareholders	$	(0.15	)	$	(1.58	)	$	(0.09	)

(1) For the years ended December 28, 2024, December 30, 2023 and December 31, 2022, 1,026,759, 1,273,093 and 2,587,501 potential common shares were excluded from the calculation of diluted loss per share due to their effect of reducing the loss per share from continuing operations attributable to common shareholders. Dilutive potential common shares consist of stock options, RSUs, and certain contingently issuable PSUs. In addition, for the years ended December 28, 2024, December 30, 2023 and December 31, 2022, stock options and RSUs to purchase or receive 1,238,722, 2,192,677 and 2,427,146 potential common shares, respectively, were anti-dilutive because the assumed proceeds exceeded the average market price of the Common Shares for the respective periods.

(2) For the years ended December 28, 2024, December 30, 2023 and December 31, 2022, it was more dilutive to the loss per share from continuing operations to assume the Series B-1 Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted loss per share calculation was not adjusted to add back the dividends and accretion on the Series B-1 Preferred Stock and the denominator was not adjusted to include the approximately 6,089,333, 6,089,333 and 12,178,667 Common Shares issuable on an if-converted basis as at December 28, 2024, December 30, 2023 and December 31, 2022, respectively.